Address	3-5, Impasse Reille Paris Ile-de-France 75014 France
Employees	-
Website	http://www.neovacs.fr
Updated	07/08/2019
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory and cancerous diseases. It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis and Interferon-Kinoid for treating lupus. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France.